Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Frasure-Smith

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Biological Psychiatry|January 11, 2007
Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromesNancy Frasure-Smith, François Lespérance, Michael R Irwin, et al.
The Journal of Clinical Psychiatry|June 30, 2010
The efficacy of omega-3 supplementation for major depression: a randomized controlled trialFrançois Lespérance, Nancy Frasure-Smith, Elise St-André, et al.
Circulation. Heart Failure|March 24, 2012
Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure TrialNancy Frasure-Smith, François Lespérance, Mario Talajic, et al.
International Journal of Hypertension|October 27, 2011
Depressive Symptoms and 24-Hour Ambulatory Blood Pressure in Africans: The SABPA StudyMark Hamer, Nancy Frasure-Smith, François Lespérance, et al.
Circulation|July 1, 2009
Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failureNancy Frasure-Smith, François Lespérance, Martine Habra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 16, 2007
Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro studyDan Atar, Alex Malinin, Alex Pokov, et al.
Journal of the American College of Cardiology|December 26, 2012
Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failureIrina Suman-Horduna, Denis Roy, Nancy Frasure-Smith, et al.
Psychosomatic Medicine|March 24, 2006
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotoninJeanne M McCaffery, Nancy Frasure-Smith, Marie-Pierre Dubé, et al.
American Heart Journal|October 2, 2004
Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder?Kim L Lavoie, Richard P Fleet, Francois Lespérance, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 17, 2003
An open-label study of nefazodone treatment of major depression in patients with congestive heart failureFrançois Lespérance, Nancy Frasure-Smith, Marc-André Laliberté, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Biological Psychiatry|January 11, 2007
Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromesNancy Frasure-Smith, François Lespérance, Michael R Irwin, et al.
The Journal of Clinical Psychiatry|June 30, 2010
The efficacy of omega-3 supplementation for major depression: a randomized controlled trialFrançois Lespérance, Nancy Frasure-Smith, Elise St-André, et al.
Circulation. Heart Failure|March 24, 2012
Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure TrialNancy Frasure-Smith, François Lespérance, Mario Talajic, et al.
International Journal of Hypertension|October 27, 2011
Depressive Symptoms and 24-Hour Ambulatory Blood Pressure in Africans: The SABPA StudyMark Hamer, Nancy Frasure-Smith, François Lespérance, et al.
Circulation|July 1, 2009
Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failureNancy Frasure-Smith, François Lespérance, Martine Habra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 16, 2007
Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro studyDan Atar, Alex Malinin, Alex Pokov, et al.
Journal of the American College of Cardiology|December 26, 2012
Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failureIrina Suman-Horduna, Denis Roy, Nancy Frasure-Smith, et al.
Psychosomatic Medicine|March 24, 2006
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotoninJeanne M McCaffery, Nancy Frasure-Smith, Marie-Pierre Dubé, et al.
American Heart Journal|October 2, 2004
Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder?Kim L Lavoie, Richard P Fleet, Francois Lespérance, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 17, 2003
An open-label study of nefazodone treatment of major depression in patients with congestive heart failureFrançois Lespérance, Nancy Frasure-Smith, Marc-André Laliberté, et al.
Pageof 7